Assoc Dir Health Economics & Outcomes Research, Solid Tumors

Associate Director

As an Associate Director you will develop HEOR strategies and plans, conduct HEOR and RWE studies and develop publications and deliverables. We work closely with Market Access, Medical Affairs, Clinical Development, Commercial, Regulatory and other groups to ensure evidence needs are identified and addressed to demonstrate the value with a focus on solid tumors.

This position is at our Sleepy Hollow, NY location and will require you to be onsite 4 days/week. We cannot offer a remote option. If eligible, we can offer relocation benefits.

A typical day may include the following:

• Develop and implement global HEOR strategies and programs for our portfolio throughout the product's lifecycle, to inform and support clinical development and regulatory needs during early pipeline phase and ensuring optimal market access.
• Collaborate with business partners to develop and support compelling product value propositions with aim to optimize future patient access.
• Identify HEOR evidence requirements and gaps, and design, conduct, and deliver studies and tools to support relative value demonstration and product differentiation.
• Leverage RWD analytic tools and collaborate with HEOR RWDnA and Epidemiology teams generating insights to inform development programs and key business questions.
• Co-lead conduct of regulatory-grade real world evidence studies and provide education on emerging opportunities for employing RWE across the solid tumor portfolio.
• Collaborate on conduct and communication of epidemiology and pharmacoepidemiology analyses and studies.
• Provide relevant input into selection of patient population, comparators and endpoints within clinical trials to enable demonstration of robust incremental value over standard of care that can facilitate optimal future patient access.
• Develop and implement Clinical Outcomes Assessment (COA) measurement strategies and plans in support of product labeling, patient access and product differentiation.
• Develop and validate COA endpoints for integration in clinical studies. Produce COA evidence dossiers for regulatory submissions.
• Evaluate relevant payer and health technology assessment (HTA) decisions, collect feedback in advisory meetings and apply key learnings to pipeline products.
• Maintain an up-to-date awareness of regulatory (e.g. FDA, EMA) and payer/HTA considerations that may impact planning for and implementation of HEOR programs.
• Report, publish and disseminate HEOR data and study results in compliance with company, industry and regulatory requirements.

This may be for you if you:

• Want to have an impact on patient lives
• Enjoy working in a 'rapid response' environment
• Would like an opportunity to present to senior leaders
• Want to be part of a growing high performing team

To be considered it is required to have an Advanced graduate degree (Ph.D., MS, or MD, PharmD., B.Pharm with Master's degree) in HEOR-related field (e.g. pharmacoepidemiology, epidemiology, healthcare/data analytics, health economics, health services research, public health). 4+ years with PhD or 6+ years with MS in HEOR; at least 3 years of life science company or healthcare consulting experience is a plus. Strong technical expertise required in design and conduct of HEOR studies and models. Solid understanding of regulatory (e.g. FDA, EMA) and HTA considerations. Experience in design and implementation of patient experience data in clinical trials, including experience in instrument selection, analysis and reporting of data. Experience with Oncology is preferred.